Análisis de la cuota de mercado y oportunidades de la terapia para el trastorno del deseo sexual hipoactivo femenino (TDAH) 2025-2031
Female Hypoactive Sexual Desire Disorder Therapeutics Market Report Analysis
Female Hypoactive Sexual Desire Disorder Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Allergan plc
- AMAG Pharmaceuticals, Inc.
- Emotional Brain BV
- Endoceutics, Inc.
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Palatin Technologies Inc
- Pivot Pharmaceuticals Inc
- Sprout Pharmaceuticals, Inc.
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Terapia
- testosterona
- flibanserina
- buspirona
- bupropión
- bremelanotida
- terapia cognitivo-conductual
By Solicitud
- paciente hospitalizado
- ambulatorio
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For